NSETrading Window1d ago · 24 Sept 2026, 02:24 pm

Trading Window

SMS Pharmaceuticals Limited · SMSPHARMA

✦ AI Summary

SMS Pharmaceuticals Limited has informed the Exchange regarding the closure of its Trading Window pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, from 01st October, 2026 till 48 hours after the declaration of financial results for the Second quarter and half year ended 30th September, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

SMS Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Attachments (1)

📄

SMSPHARMA_24092026142358_Trading_window_closure_Sep_2026.pdf

pdf

Download →
View document text
Date: 24th September 2026 The Manager, The Manager, Corporate Filings Department, Listing Compliance Department, BSE Limited, National Stock Exchange of India Ltd., Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/1, G Block, Dalal Street, Bandra-Kurla Complex, Bandra (E), Mumbai- 400 001 Mumbai - 400 051. Security Code: 532815 Symbol: SMSPHARMA Subject: Intimation of closure of Trading Window: This is to inform that, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, read with the relevant circulars issued by BSE Limited and National Stock Exchange of India Limited and company's Code of Conduct for Prevention of Insider Trading of the Company, the Trading Window for dealing in shares of the Company for all designated persons and their immediate relatives shall remain closed from 01st October, 2026 till 48 hours after the declaration of financial results for the Second quarter and half year ended 30th September, 2026. The date of Board Meeting for the consideration of financial results of the Company for the second quarter and half year ended 30th September, 2026 shall be intimated in due course of time. This is for your information and records. Thanking you Yours faithfully For SMS Pharmaceuticals Limited Thirumalesh Tumma Company Secretary